t
Braveheart Investment Group Plc announced on 04 March 2024 the completion of the sale of Phasefocus Holdings Limited to Bruker UK Limited, as previously announced on 22 December 2023. Braveheart received approximately £2.1 million in proceeds (after expenses) from this sale. This transaction represents a gain of £1.31 million over cost and a Compound Annual Growth Rate (CAGR) of 48.29%.
| Date | 4 Mar 2024 |
| Time | 07:00:05 |
| Category | Disposals |
| ID | 3628F |
4 March 2024
Braveheart Investment Group Plc
("Braveheart", the "Company" or the "Group")
Completion of sale of Phasefocus
Braveheart Investment Group (AIM: BRH), is pleased to announce that, further to the announcement on 22 December 2023 regarding the sale of Phasefocus Holdings Limited ("Phasefocus") to Bruker UK Limited, all outstanding conditions to the sale have now been satisfied and the sale has therefore completed. The total proceeds receivable by the Company for the Sale was approximately £2.1 million (after expenses).
Trevor Brown, CEO of Braveheart, commented: "The sale of our holding in Phasefocus represents a gain of £1.31m over cost, which is a highly satisfactory CAGR of 48.29% for Braveheart shareholders."
For further information:
|
Braveheart Investment Group plc |
Tel: 01738 587555 |
|
Trevor Brown, Chief Executive Officer Viv Hallam, Executive Director |
|
|
Allenby Capital Limited (Nominated Adviser and Joint Broker) |
Tel: 020 3328 5656 |
|
James Reeve / George Payne |
|
|
|
|
|
Peterhouse Capital Limited (Joint Broker) |
Tel: 020 7469 0936 |
|
Duncan Vasey / Lucy Williams
|
|